96-week efficacy and safety of atazanavir, with and without ritonavir, in a HAART regimen in treatment-naive patients. [electronic resource]
Producer: 20110517Description: 34-42 p. digitalISSN:- 1545-1097
- Adult
- Aged
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active
- Atazanavir Sulfate
- Drug Resistance, Viral -- genetics
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Male
- Middle Aged
- Oligopeptides -- administration & dosage
- Prospective Studies
- Pyridines -- administration & dosage
- RNA, Viral -- blood
- Ritonavir -- administration & dosage
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.